Why patent owners in India should aim for interim relief

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Why patent owners in India should aim for interim relief

Patent owners in India who are litigating their rights should try to obtain interim relief. If they don’t, they face protracted and expensive patent battles, warned an Indian lawyer last week

Essenese Obhan

Essenese Obhan of Obhan & Associates discussed this and other tips for rights holders interested in doing business in India at Managing IP’s China – International IP Forum last week.

One important feature of India’s patent law is that under Section 13(4) of the Act, there is no presumption of patent validity even if there has been a substantive examination, he explained. Because of this, patent applicants must prepare carefully in the case of pre-grant or post-grant opposition.

“In litigation, you will need a strong procedural case, as well as strong technical support for your patent”, he said.

To get interim relief such as an injunction against the opposing party, said Obhan, the rights holder must to establish a prima facie case as to the patent’s validity. Complying with all the procedural requirements is crucial to building that case.

One important pre-grant requirement is submitting information about parallel applications in other countries, said Obhan. The statement must include a list of the countries in which the patent has been filed, date of application, application number, status, and the publication and grant dates.

In addition, the applicant may be required to provide information about the application status in other countries, including if there were objections to the novelty and patentability of the invention.

This information must be submitted within six months of filing and periodically updated until the patent is granted.

Obhan said that failure to provide this information in a timely manner compromises the applicant’s case for prima facie validity. It also damages the applicant’s credibility with the registrar.

Procedural correctness is also extremely important in building a post-grant case for prima facie validity, he said.

One requirement that often gives companies trouble is the “statement of working”, which must be filed by March 31 of each year. The filing must state whether the patent is being worked, and if so, details such as the “quantum and value” of the product, Obhan explained, as well as whether it is manufactured in India and whether it is being imported elsewhere. The statement must also give information such as whether licenses have been granted.

If the patent is not being worked, Obhan said, the applicant must explain why that is, and what steps are being taken to commercialise the innovation.

Failure to file this statement implies that the patent is “non-working” and also creates grounds to grant a compulsory licence, said Obhan. It may also lead to a fine of up to INR 1 million ($17,551.83).

Despite the dangers of not filing, Obhan warned rights holders who are tempted to submit false information of the dangers of doing so. He pointed out that filing false information could result in a fine of up to INR 1 million as well as six months in jail.

Managing IP’s China – International IP Forum took place on June 20 and 21 in Beijing.








more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article